We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Law Firm Pushes FDA to Rethink Limits on Meeting Senior Staff
Law Firm Pushes FDA to Rethink Limits on Meeting Senior Staff
A law firm that represents drugmakers is urging the FDA to rethink its stance on granting meetings with senior agency officials, saying the existing policy can imperil drug research.